Atlas Trials

Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR

Clinical trial NCT01364155 · UNKNOWN

Trial details

NCT number
NCT01364155
Sponsor
Limerick BioPharma
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Impaired Glucose ToleranceInsulin Resistance
Start date
2011-05-01
Primary completion
2011-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.